Image

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Study of Zanidatamab for HER2-expressing Tumors

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

The purpose of this study is to investigate HER2-expressing tumors. This study will look at how the investigational medication, zanidatamab, works for people who have already been treated for this condition.

This study evaluates the safety and effectiveness of the investigational medication. Researchers want to understand how well the medication works and if it is safe for people with the condition.

  • Who can participate: Adults aged 18 and older with HER2-expressing tumors may participate. Participants must have previously treated solid tumors and meet certain health criteria.
  • Study details: Participants will receive the investigational medication zanidatamab.
Print
Study details
    Breast Cancer
    Gastric Cancer
    Esophageal Cancer
    Gastroesophageal Cancer
    Colorectal Cancer
    Endometrial Cancer
    Non-small Cell Lung Cancer
    Ovarian Cancer
    Urothelial Carcinoma
    Salivary Gland Cancer
    Pancreatic Cancer
    HER-2 Protein Overexpression

NCT06695845

Jazz Pharmaceuticals

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.